Everything below concerns cyclic heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-05-30. Numbers and descriptions here follow the published literature rather than marketing material.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
The twenty-foot equivalent unit is the volume of the smallest standard shipping container. It is equivalent to 1,172 cubic feet (33.2 m3). Larger intermodal containers are commonly described in multiples of TEU, as are container ship capacities.
== Notable researchers == Roger Guillemin and Andrew W. Schally were awarded the Nobel Prize in Physiology and Medicine in 1977 for their contributions to understanding "the peptide hormone production of the brain"; these scientists independently first isolated TRH and GnRH and then identified their structures.
Colonial administration records (migrated archives): Malaya at The National Archives (Pg. 52) The UK Statute Law Database: Federation of Malaya Independence Act 1957 (c. 60) United Nations Treaty Collection: No.10760: Agreement relating to Malaysia FEDERATION OF MALAYA AGREEMENT OF 5 AUGUST 1957 Media related to Federation of Malaya at Wikimedia Commons
Rabson–Mendenhall syndrome is a rare autosomal recessive disorder characterized by severe insulin resistance. The disorder is caused by mutations in the insulin receptor gene. Symptoms include growth abnormalities of the head, face and nails, along with the development of acanthosis nigricans. Treatment involves controlling blood glucose levels by using insulin and incorporating a strategically planned, controlled diet. Also, direct actions against other symptoms may be taken (such as surgery for facial abnormalities). Only about 50 cases have been reported and affected patients usually die during adolescence.
== Background == The conflict occurred against the backdrop of long-running tensions between Afghanistan and Pakistan rooted in disputes dating back to the independence of Pakistan in 1947. Afghanistan has historically challenged the legitimacy of the Durand Line, which forms the international border between the two nations, contributing to decades of strained relations and periodic clashes. Relations deteriorated further following the Taliban's return to power in 2021 in the aftermath of the US withdrawal from Afghanistan. Pakistan has repeatedly accused Afghanistan of providing safe haven to militant groups, particularly the Tehreek-e-Taliban Pakistan (TTP), which has carried out attacks in Pakistan in order to establish an Islamic emirate, similar to the model of government in Afghanistan. Taliban authorities have generally denied these allegations. Tensions escalated in 2025 after a surge in cross-border violence and militant attacks. In October 2025, some of the deadliest clashes in years led to a Qatar-mediated ceasefire, but its implementation proved to be fragile, and follow-up talks in Doha and Istanbul failed to produce a lasting agreement. Low-level skirmishes continued along the border in the following months. In early 2026, Pakistan experienced a series of major attacks, primarily in its frontier provinces of Balochistan and Khyber Pakhtunkhwa, alongside a major suicide bombing in the capital of Islamabad.
Sources: en.wikipedia.org
==== 2010s ==== Every Paradise Bakery & Café location was rebranded in September 2015 as Panera Bread. In the fourth quarter of 2015, Panera acquired a majority stake in Tatte Bakery & Café, a bakery-cafe concept chain with locations in the Boston area, later opening in metro Washington D.C. On March 23, 2016, Panera opened its 2,000th location, a cafe in Elyria, Ohio. In January 2017, Panera announced its food menu was free of artificial colors, flavors, sweeteners, and preservatives. JAB Holding Company acquired the company on July 11, 2017, for $7.5 billion. On November 8, 2017, Panera announced that founder Ron Shaich was stepping down as CEO, and company president Blaine Hurst would take over. Shaich remained chairman. The company also announced the acquisition of Au Bon Pain. Panera divested Tatte Bakery & Café to Act III Holdings, LLC, owned by Shaich in January 2018. In January 2018, the company formed a consulting business to help restaurants remove artificial ingredients from their menus. On April 2, 2018, Brian Krebs reported that the Panera Bread website had leaked between 7 million and 37 million customer records— including names, email, and physical addresses, customer loyalty account numbers, birthdays, and last four digits of the customers' credit card numbers— for at least eight months before the site was taken offline. Panera was notified privately about the vulnerability in August 2017 but failed to fix it until after it was disclosed publicly eight months later. Panera said the leak affected fewer than 10,000 customers and had been fixed.
==== Functional or Mean Fields Model ==== The functional or mean fields model relies on the premise "simpler is better". It strives to reduce the complexity of modelling multi-faceted systems by using a single variable to describe an entire population of cells. The alternative would be to use a different set of variables for each population. When attempting to model a system where multiple populations of cells interact, using several sets quickly becomes overcomplicated. This model has been used to describe several systems, especially involving the reproductive cycle (menstrual cycles, luteinizing hormone, prolactin surges). Functional models also exist to represent cortisol secretion, and growth hormone secretion.
=== Occurrence in space === Nitriles are among the most abundant organic molecules in space, and more than ten distinct compounds have been unequivocally detected. Hydrogen cyanide was one of the first polyatomic species identified in space and occurs there relatively frequently and in substantial quantities. Other nitriles detected in space include acetonitrile and aminoacetonitrile, as well as butyronitrile, cyanoacetylene, and cyanopolyins containing two to five conjugated triple bonds. Hydrogen cyanide, cyanoacetylene, and cyanogen are present in the atmosphere of Saturn's moon Titan.
=== Former faculty === Persons who had left the faculty through death, retirement, termination, or by accepting an offer somewhere else. Former members of the faculty are listed by divisions. Alumnus degrees are depicted in italic type.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.